Search research articles
Contact Us
Filters
Showing results (11-20 of 32) with videos related to
Page
of 4
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 22, 2016
Multigene Measurable Residual Disease Assessment Improves Acute Myeloid Leukemia Relapse Risk Stratification in Autologous Hematopoietic Cell Transplantation
Matthew P Mulé, Gabriel N Mannis, Brent L Wood, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 2, 2019
Limitation in Patient-Reported Function Is Associated with Inferior Survival in Older Adults Undergoing Autologous Hematopoietic Cell Transplantation
Mariam T Nawas, Charalambos Andreadis, Thomas G Martin, et al.
Transplantation and Cellular Therapy
|
March 5, 2022
Patterns and Predictors of Functional Decline after Allogeneic Hematopoietic Cell Transplantation in Older Adults
Li-Wen Huang, Ying Sheng, Charalambos Andreadis, et al.
Journal of Geriatric Oncology
|
October 16, 2020
Serial comprehensive geriatric and quality of life assessments in adults age ≥ 50 years undergoing autologous hematopoietic cell transplantation
Mariam T Nawas, Ying Sheng, Chiung-Yu Huang, et al.
American Journal of Clinical Pathology
|
April 21, 2024
p53 immunohistochemistry as an ancillary tool for rapid assessment of residual disease in TP53-mutated acute myeloid leukemia and myelodysplastic syndromes
Nivaz Brar, Lauren Lawrence, Eula Fung, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 8, 2019
Functional Status as Measured by Geriatric Assessment Predicts Inferior Survival in Older Allogeneic Hematopoietic Cell Transplantation Recipients
Li-Wen Huang, Ying Sheng, Charalambos Andreadis, et al.
Journal of Geriatric Oncology
|
September 7, 2023
Association of geriatric measures and global frailty with cognitive decline after allogeneic hematopoietic cell transplantation in older adults
Li-Wen Huang, Ying Shi, Charalambos Andreadis, et al.
Blood Neoplasia
|
September 11, 2025
V-FAST: a phase 1b master trial to investigate CPX-351 combined with targeted agents in adults with newly diagnosed AML
Vinod A Pullarkat, Mark Levis, James McCloskey, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 23, 2016
Quantification of Acute Lymphoblastic Leukemia Clonotypes in Leukapheresed Peripheral Blood Progenitor Cells Predicts Relapse Risk after Autologous Hematopoietic Stem Cell Transplantation
Gabriel N Mannis, Thomas G Martin, Lloyd E Damon, et al.
Leukemia & Lymphoma
|
October 23, 2015
Long-term outcomes of patients with intermediate-risk acute myeloid leukemia treated with autologous hematopoietic cell transplant in first complete remission
Gabriel N Mannis, Thomas G Martin, Lloyd E Damon, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 32) with videos related to
Sort By:
Page
of 4
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 22, 2016
Multigene Measurable Residual Disease Assessment Improves Acute Myeloid Leukemia Relapse Risk Stratification in Autologous Hematopoietic Cell Transplantation
Matthew P Mulé, Gabriel N Mannis, Brent L Wood, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 2, 2019
Limitation in Patient-Reported Function Is Associated with Inferior Survival in Older Adults Undergoing Autologous Hematopoietic Cell Transplantation
Mariam T Nawas, Charalambos Andreadis, Thomas G Martin, et al.
Transplantation and Cellular Therapy
|
March 5, 2022
Patterns and Predictors of Functional Decline after Allogeneic Hematopoietic Cell Transplantation in Older Adults
Li-Wen Huang, Ying Sheng, Charalambos Andreadis, et al.
Journal of Geriatric Oncology
|
October 16, 2020
Serial comprehensive geriatric and quality of life assessments in adults age ≥ 50 years undergoing autologous hematopoietic cell transplantation
Mariam T Nawas, Ying Sheng, Chiung-Yu Huang, et al.
American Journal of Clinical Pathology
|
April 21, 2024
p53 immunohistochemistry as an ancillary tool for rapid assessment of residual disease in TP53-mutated acute myeloid leukemia and myelodysplastic syndromes
Nivaz Brar, Lauren Lawrence, Eula Fung, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 8, 2019
Functional Status as Measured by Geriatric Assessment Predicts Inferior Survival in Older Allogeneic Hematopoietic Cell Transplantation Recipients
Li-Wen Huang, Ying Sheng, Charalambos Andreadis, et al.
Journal of Geriatric Oncology
|
September 7, 2023
Association of geriatric measures and global frailty with cognitive decline after allogeneic hematopoietic cell transplantation in older adults
Li-Wen Huang, Ying Shi, Charalambos Andreadis, et al.
Blood Neoplasia
|
September 11, 2025
V-FAST: a phase 1b master trial to investigate CPX-351 combined with targeted agents in adults with newly diagnosed AML
Vinod A Pullarkat, Mark Levis, James McCloskey, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 23, 2016
Quantification of Acute Lymphoblastic Leukemia Clonotypes in Leukapheresed Peripheral Blood Progenitor Cells Predicts Relapse Risk after Autologous Hematopoietic Stem Cell Transplantation
Gabriel N Mannis, Thomas G Martin, Lloyd E Damon, et al.
Leukemia & Lymphoma
|
October 23, 2015
Long-term outcomes of patients with intermediate-risk acute myeloid leukemia treated with autologous hematopoietic cell transplant in first complete remission
Gabriel N Mannis, Thomas G Martin, Lloyd E Damon, et al.
Page
of 4